Dermatology
Cellulitis and Erysipelas
Eron class severity grading, IV vs oral antibiotic decision, and marking for monitoring
Source: NICE NG141 2019 / CREST
Step 1 of ~9
info
Cellulitis Assessment
Cellulitis: non-elevated erythema, ill-defined border, deeper dermis/subcutaneous tissue. Erysipelas: well-demarcated, raised, superficial. Both caused by Streptococcus (Group A/B/C/G) and Staphylococcus aureus. Mark erythema border with pen and timestamp.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Doxycycline 100mg (Acne / Rosacea) · Oral tetracycline antibiotic (anti-acne / anti-rosacea)
- Lymecycline 408mg (Acne) · Oral tetracycline antibiotic (anti-acne)
- Clindamycin · Lincosamide Antibiotic
- Teicoplanin · Glycopeptide Antibiotic — MRSA / Gram-Positive Infections
- Fosfomycin · Phosphonic Acid Antibiotic — Uncomplicated UTI / ESBL / MDR Gram-Negatives
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
- Non-Melanoma Skin Cancer — BCC and SCC · NICE NG12 2015 / BAD NMSC Guidelines
Decision support only. Always apply local guidelines and clinical judgement.